Last week, a pharmaceutical drug, Remdesivir, was presented to the world, allegedly to help patients infected during the pandemic. Does this drug bring justified hope – or is it just hype?
Fin avril, un médicament pharmaceutique, le Remdesivir, a été présenté au monde entier, prétendument pour aider les patients infectés pendant la pandémie. Ce médicament apporte-t-il un espoir justifié – ou s’agit-il simplement d’un battage médiatique ?
A finales de Abril, se presentó al mundo un medicamento farmacéutico, Remdesivir, presuntamente para ayudar a pacientes infectados durante la pandemia. ¿Trae este fármaco esperanza justificada, o es solo una exageración?
A recent systematic review and meta-analysis of observational studies examines the association between vitamin C levels and blood pressure. Analyzing a total of 18 studies involving […]
Established in 1963, the Codex Alimentarius Commission (CODEX) is responsible for creating global standards, guidelines and codes of practice for the food and nutrition industries.
A new lab test can identify which children with CAD deficiency, a rare neurometabolic disorder, are likely to benefit from a nutritional supplement containing uridine. One of the five standard nucleosides which make up DNA and RNA, uridine has dramatically improved the lives of other children with the condition.
A new, multi-ethnic study found older adults with low vitamin K levels were more likely to die within 13 years compared to those whose vitamin K levels were adequate.
Vitamin D Deficiency Associated With Reduced Survival For Patients With Multiple Myeloma
A new study has found that vitamin D deficiency is associated with reduced overall survival for patients with multiple myeloma.